Siirry pääsisältöön
Käyttämääsi selainta ei enää tueta – lue lisää.

ExpreS2ion Biotech Holding

Ylin-
Alin-
Vaihto-
2026 Q2 - tulosraportti
42 päivää sitten

Tarjoustasot

Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
464--
9--
27--
5 135--
2 865--

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Rahastot ja ETF:t, joilla on osaketta

Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.

Yhtiötapahtumat

Datan lähde: Quartr
Seuraava tapahtuma
2026 Q3 - tulosraportti
12.11.
Menneet tapahtumat
2026 Q2 - tulosraportti
20.8.
2026 Q1 - tulosraportti
28.5.
2025 Q4 - tulosraportti
19.2.
2025 Q3 - tulosraportti
13.11.2025
2025 Q2 - tulosraportti
21.8.2025

Uutiset

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 24.9.
    Such bad incompetent company- they have nothing in their hands but share holder many to pay their bills
    25.9.
    ·
    My question is when a forced sale will actually become a contingency? 2027 will probably be their last year?? Or what do you others think.
  • 23.9.
    ·
    Under 1% subscribed 😱. Has that ever been seen before?
    24.9.
    ·
    AP - They get 60% of the guarantee covered by their guarantor, and you all experience a very large dilution at a low price. The desire from private investors to finance this nonsense has run out, and the money they are getting now will probably last 6 months, then new emissions are needed as all other borrowing options are exhausted. Either you are currently living at the guarantor's mercy or else it is the end of that company before 2027 is over.
  • 19.9.
    ·
    Yes. once again, the management in this and other biotech companies gives away the shares to the guarantors at a spot price, instead of setting the price for the newly issued shares down to the same for the existing shareholders. Then the existing shareholders would probably largely participate in the issue instead of, as now, being left in the lurch and a ridiculous price of 1.6 SEK per newly issued share, while the guarantors run away with the new shares at a spot price I don't even bother to calculate precisely, but which probably actually is around 1.15 SEK. Vator Securities will receive a fee corresponding to 10 percent of the guaranteed amount in cash and 30 percent of the guaranteed amount in newly issued shares in the Company. The consideration shares will be issued at SEK 1.60 per share, equal to the TO 13 exercise price and a premium of approximately 28 percent to the closing price of SEK 1.25 on Nasdaq First North Growth Market on 14 September 2026. Measured against that closing price, the compensation to guarantors corresponds to an effective guarantee fee (in cash and newly issued shares) of approximately 12 percent.
    23.9.
    ·
    Yes, we must hope for a very good readout and pleeeeeease a partner soon for this.
  • 18.9.
    ·
    If the guarantors receive a compensation of 40%, does that mean their real price is 60% of SEK 1.6 - i.e. SEK 0.96??? If that is true, that price must be the next bottom until any good news can drive the price up again.
  • 17.9.
    ·
    I just had a small meeting with AI. Question: what do guarantors pay per to13 Guarantors' remuneration (Guarantor commission)Since the company's share price on the stock exchange is lower than SEK 1.60, no external investors would buy shares at that price without getting something extra. ExpreS2ion Biotech therefore pays the guarantors a total compensation of 40 % of the guaranteed amount:💵 10 % in cash: The guarantors receive a cash commission.📈 30 % in new shares: The guarantors receive free, newly issued shares as a thank you for their help.🔍 What does that mean for the real price? When offsetting the cash and free shares the guarantors receive, their actual acquisition price per share ends up being significantly lower than SEK 1.60. According to the analysis firm Inderes, the board has assessed that this model was, after all, better and resulted in less dilution for existing shareholders than having to start a completely new, large, and expensive rights issue from scratch. Note: The actual transfer of shares to the guarantors takes place via a directed issue (Directed Issue), which is expected to be formally approved at an extraordinary general meeting around October 1, 2026.
    18.9.
    ·
    If the guarantors receive a compensation of 40%, does that mean their real price is 60% of SEK 1.6 - i.e. SEK 0.96??? If that is true, that price must be the next bottom until any good news can drive the price up again.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tuotteita joiden kohde-etuutena tämä arvopaperi

Välittäjätilasto

Dataa ei löytynyt
2026 Q2 - tulosraportti
42 päivää sitten

Uutiset

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 24.9.
    Such bad incompetent company- they have nothing in their hands but share holder many to pay their bills
    25.9.
    ·
    My question is when a forced sale will actually become a contingency? 2027 will probably be their last year?? Or what do you others think.
  • 23.9.
    ·
    Under 1% subscribed 😱. Has that ever been seen before?
    24.9.
    ·
    AP - They get 60% of the guarantee covered by their guarantor, and you all experience a very large dilution at a low price. The desire from private investors to finance this nonsense has run out, and the money they are getting now will probably last 6 months, then new emissions are needed as all other borrowing options are exhausted. Either you are currently living at the guarantor's mercy or else it is the end of that company before 2027 is over.
  • 19.9.
    ·
    Yes. once again, the management in this and other biotech companies gives away the shares to the guarantors at a spot price, instead of setting the price for the newly issued shares down to the same for the existing shareholders. Then the existing shareholders would probably largely participate in the issue instead of, as now, being left in the lurch and a ridiculous price of 1.6 SEK per newly issued share, while the guarantors run away with the new shares at a spot price I don't even bother to calculate precisely, but which probably actually is around 1.15 SEK. Vator Securities will receive a fee corresponding to 10 percent of the guaranteed amount in cash and 30 percent of the guaranteed amount in newly issued shares in the Company. The consideration shares will be issued at SEK 1.60 per share, equal to the TO 13 exercise price and a premium of approximately 28 percent to the closing price of SEK 1.25 on Nasdaq First North Growth Market on 14 September 2026. Measured against that closing price, the compensation to guarantors corresponds to an effective guarantee fee (in cash and newly issued shares) of approximately 12 percent.
    23.9.
    ·
    Yes, we must hope for a very good readout and pleeeeeease a partner soon for this.
  • 18.9.
    ·
    If the guarantors receive a compensation of 40%, does that mean their real price is 60% of SEK 1.6 - i.e. SEK 0.96??? If that is true, that price must be the next bottom until any good news can drive the price up again.
  • 17.9.
    ·
    I just had a small meeting with AI. Question: what do guarantors pay per to13 Guarantors' remuneration (Guarantor commission)Since the company's share price on the stock exchange is lower than SEK 1.60, no external investors would buy shares at that price without getting something extra. ExpreS2ion Biotech therefore pays the guarantors a total compensation of 40 % of the guaranteed amount:💵 10 % in cash: The guarantors receive a cash commission.📈 30 % in new shares: The guarantors receive free, newly issued shares as a thank you for their help.🔍 What does that mean for the real price? When offsetting the cash and free shares the guarantors receive, their actual acquisition price per share ends up being significantly lower than SEK 1.60. According to the analysis firm Inderes, the board has assessed that this model was, after all, better and resulted in less dilution for existing shareholders than having to start a completely new, large, and expensive rights issue from scratch. Note: The actual transfer of shares to the guarantors takes place via a directed issue (Directed Issue), which is expected to be formally approved at an extraordinary general meeting around October 1, 2026.
    18.9.
    ·
    If the guarantors receive a compensation of 40%, does that mean their real price is 60% of SEK 1.6 - i.e. SEK 0.96??? If that is true, that price must be the next bottom until any good news can drive the price up again.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
464--
9--
27--
5 135--
2 865--

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Rahastot ja ETF:t, joilla on osaketta

Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.

Yhtiötapahtumat

Datan lähde: Quartr
Seuraava tapahtuma
2026 Q3 - tulosraportti
12.11.
Menneet tapahtumat
2026 Q2 - tulosraportti
20.8.
2026 Q1 - tulosraportti
28.5.
2025 Q4 - tulosraportti
19.2.
2025 Q3 - tulosraportti
13.11.2025
2025 Q2 - tulosraportti
21.8.2025

Tuotteita joiden kohde-etuutena tämä arvopaperi

Välittäjätilasto

Dataa ei löytynyt
2026 Q2 - tulosraportti
42 päivää sitten

Uutiset

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Yhtiötapahtumat

Datan lähde: Quartr
Seuraava tapahtuma
2026 Q3 - tulosraportti
12.11.
Menneet tapahtumat
2026 Q2 - tulosraportti
20.8.
2026 Q1 - tulosraportti
28.5.
2025 Q4 - tulosraportti
19.2.
2025 Q3 - tulosraportti
13.11.2025
2025 Q2 - tulosraportti
21.8.2025

Tuotteita joiden kohde-etuutena tämä arvopaperi

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 24.9.
    Such bad incompetent company- they have nothing in their hands but share holder many to pay their bills
    25.9.
    ·
    My question is when a forced sale will actually become a contingency? 2027 will probably be their last year?? Or what do you others think.
  • 23.9.
    ·
    Under 1% subscribed 😱. Has that ever been seen before?
    24.9.
    ·
    AP - They get 60% of the guarantee covered by their guarantor, and you all experience a very large dilution at a low price. The desire from private investors to finance this nonsense has run out, and the money they are getting now will probably last 6 months, then new emissions are needed as all other borrowing options are exhausted. Either you are currently living at the guarantor's mercy or else it is the end of that company before 2027 is over.
  • 19.9.
    ·
    Yes. once again, the management in this and other biotech companies gives away the shares to the guarantors at a spot price, instead of setting the price for the newly issued shares down to the same for the existing shareholders. Then the existing shareholders would probably largely participate in the issue instead of, as now, being left in the lurch and a ridiculous price of 1.6 SEK per newly issued share, while the guarantors run away with the new shares at a spot price I don't even bother to calculate precisely, but which probably actually is around 1.15 SEK. Vator Securities will receive a fee corresponding to 10 percent of the guaranteed amount in cash and 30 percent of the guaranteed amount in newly issued shares in the Company. The consideration shares will be issued at SEK 1.60 per share, equal to the TO 13 exercise price and a premium of approximately 28 percent to the closing price of SEK 1.25 on Nasdaq First North Growth Market on 14 September 2026. Measured against that closing price, the compensation to guarantors corresponds to an effective guarantee fee (in cash and newly issued shares) of approximately 12 percent.
    23.9.
    ·
    Yes, we must hope for a very good readout and pleeeeeease a partner soon for this.
  • 18.9.
    ·
    If the guarantors receive a compensation of 40%, does that mean their real price is 60% of SEK 1.6 - i.e. SEK 0.96??? If that is true, that price must be the next bottom until any good news can drive the price up again.
  • 17.9.
    ·
    I just had a small meeting with AI. Question: what do guarantors pay per to13 Guarantors' remuneration (Guarantor commission)Since the company's share price on the stock exchange is lower than SEK 1.60, no external investors would buy shares at that price without getting something extra. ExpreS2ion Biotech therefore pays the guarantors a total compensation of 40 % of the guaranteed amount:💵 10 % in cash: The guarantors receive a cash commission.📈 30 % in new shares: The guarantors receive free, newly issued shares as a thank you for their help.🔍 What does that mean for the real price? When offsetting the cash and free shares the guarantors receive, their actual acquisition price per share ends up being significantly lower than SEK 1.60. According to the analysis firm Inderes, the board has assessed that this model was, after all, better and resulted in less dilution for existing shareholders than having to start a completely new, large, and expensive rights issue from scratch. Note: The actual transfer of shares to the guarantors takes place via a directed issue (Directed Issue), which is expected to be formally approved at an extraordinary general meeting around October 1, 2026.
    18.9.
    ·
    If the guarantors receive a compensation of 40%, does that mean their real price is 60% of SEK 1.6 - i.e. SEK 0.96??? If that is true, that price must be the next bottom until any good news can drive the price up again.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
464--
9--
27--
5 135--
2 865--

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Rahastot ja ETF:t, joilla on osaketta

Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.

Välittäjätilasto

Dataa ei löytynyt